-transparent.png){kind=logo}
The authors report the observation of one patient in whom the first administration of chemotherapy with fluoro-5 uracil has induced a severe but reversible cardiogenic shock. The latter was preceded by a prolonged, constrictive thoracic pain without myocardial infarction constitution. The cardiac toxicity of fluoro-5 uracil has been well described in the form of anginal pains receding with the discontinuation of the treatment. However, the possible occurrence of arrhythmias, of collapse and even sudden deaths leads the authors to suggest the daily clinical and electrical observation of the patients treated with fluoro-5 uractil.
Related Publications
C Mazet, and
A Dellinger, and
D Vital Durand, and
M Adnaoui, and
G Fournier, and
R Levrat
December 2019,
American journal of therapeutics,
C Mazet, and
A Dellinger, and
D Vital Durand, and
M Adnaoui, and
G Fournier, and
R Levrat
January 2014,
Case reports in oncological medicine,
C Mazet, and
A Dellinger, and
D Vital Durand, and
M Adnaoui, and
G Fournier, and
R Levrat
August 2005,
Annales de cardiologie et d'angeiologie,
C Mazet, and
A Dellinger, and
D Vital Durand, and
M Adnaoui, and
G Fournier, and
R Levrat
August 2010,
Investigational new drugs,
C Mazet, and
A Dellinger, and
D Vital Durand, and
M Adnaoui, and
G Fournier, and
R Levrat
July 1989,
American heart journal,
C Mazet, and
A Dellinger, and
D Vital Durand, and
M Adnaoui, and
G Fournier, and
R Levrat
March 2009,
Arquivos brasileiros de cardiologia,
C Mazet, and
A Dellinger, and
D Vital Durand, and
M Adnaoui, and
G Fournier, and
R Levrat
January 1989,
Presse medicale (Paris, France : 1983),
C Mazet, and
A Dellinger, and
D Vital Durand, and
M Adnaoui, and
G Fournier, and
R Levrat
February 1971,
Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
C Mazet, and
A Dellinger, and
D Vital Durand, and
M Adnaoui, and
G Fournier, and
R Levrat
January 1996,
Tumori,
C Mazet, and
A Dellinger, and
D Vital Durand, and
M Adnaoui, and
G Fournier, and
R Levrat
December 2023,
European heart journal. Case reports,
